Anesthesia Considerations for Patients with Prolonged QT Interval

A prolonged QT interval—an increase in the time between the beginning of ventricular depolarization and the end of repolarization—is a potentially dangerous side effect of many medications. Delayed cardiac repolarization can lead to serious arrhythmias and, in severe cases, cardiac arrest. One of the most concerning complications is torsades de pointes, a life-threatening arrhythmia that requires prompt recognition and treatment with intravenous magnesium, with electrical defibrillation indicated if the patient becomes hemodynamically unstable. General anesthesia can introduce several factors that increase the risk of torsades, including the use of QT-prolonging medications, perioperative electrolyte disturbances, and sympathetic stimulation in response to stress or pain. Understanding and managing these factors is important when providing anesthesia for patients with a prolonged QT interval at baseline.

A prolonged QT interval can be either congenital or acquired. Congenital long QT syndrome is relatively uncommon, affecting approximately 1 in 2,000 to 2,500 individuals (Schwartz et al., 2009). Acquired QT prolongation is most commonly associated with medications, with common contributors including macrolides, fluoroquinolones, and antidepressants (Tisdale et al., 2020). Electrolyte abnormalities, particularly hypokalemia, hypomagnesemia, and hypocalcemia, can also increase cardiac electrical instability and contribute to the development of torsades. The risk of torsades increases significantly when the corrected QT (QTc) interval exceeds 500 ms or increases by more than 60 ms from baseline.

Recognizing a prolonged QTc before surgery is an important part of preventing complications. A preoperative ECG can help identify baseline abnormalities and guide anesthetic planning. However, even when an ECG does not show an obvious abnormality, a family history of unexplained syncope or sudden cardiac death may indicate an increased risk of an underlying long QT syndrome.

Anesthesiologists can reduce the risk of torsades through careful medication selection and intraoperative management. Considerable research has examined the effects of anesthetic medications on QTc prolongation, particularly in patients who already have an increased risk of arrhythmias. Succinylcholine, which is commonly used in anesthesia to facilitate endotracheal intubation, can prolong the QT interval and may contribute to additional cardiac instability. Reversal of neuromuscular blockade also warrants caution. The combination of neostigmine and glycopyrrolate has been associated with QTc prolongation in some studies. Sugammadex may be a preferable alternative in these patients because it has generally demonstrated a lower risk of QTc prolongation compared with traditional reversal agents (Staikou et al., 2014). Antiemetics such as ondansetron should also be used cautiously because of their potential to prolong the QT interval.

Medication selection is important not only because of the direct effects certain drugs have on cardiac repolarization but also because some medications can contribute to electrolyte disturbances that further increase arrhythmia risk. Maintaining an appropriate depth of anesthesia is equally important. Inadequate anesthetic depth can lead to sympathetic stimulation in response to surgical stress or pain, potentially increasing the risk of arrhythmias. Providing adequate anesthesia and analgesia helps minimize these responses.

QT-prolonging medications and other torsadogenic factors are common in the perioperative setting, making careful planning essential. Ultimately, appropriate medication selection, maintenance of normal electrolyte levels, and control of sympathetic stimulation are all important in reducing the risks associated with prolonged QT intervals and promoting patient safety.

References

Schwartz PJ, Stramba-Badiale M, Crotti L, et al. Prevalence of the congenital long-QT syndrome. Circulation. 2009;120(18):1761-1767. doi:10.1161/CIRCULATIONAHA.109.863209

Tisdale JE, Chung MK, Campbell KB, et al. Drug-Induced Arrhythmias: A Scientific Statement From the American Heart Association. Circulation. 2020;142(15). doi:10.1161/CIR.0000000000000905

Staikou C, Stamelos M, Stavroulakis E. Impact of anaesthetic drugs and adjuvants on ECG markers of torsadogenicity. Br J Anaesth. 2014;112(2):217-230. doi:10.1093/bja/aet412